3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Paraparesis, Tropical Spastic
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Interventions
Cyclophosphamide
80
Rituximab
61
Specimen Handling
53
Doxorubicin
45
Biopsy
45
Vincristine
44
Prednisone
41
Magnetic Resonance Spectroscopy
40
venetoclax
31
obinutuzumab
29
fludarabine
29
ibrutinib
24
Methotrexate
24
Cytarabine
23
Lenalidomide
22
Dexamethasone
22
merphos
19
blinatumomab
19
Bendamustine Hydrochloride
19
Etoposide
18
zanubrutinib
17
acalabrutinib
17
prednylidene
16
fludarabine phosphate
16
deltacortene
16
Mercaptopurine
16
X-Rays
15
Calcium Dobesilate
15
pegaspargase
14
Nivolumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tenofovir
×
Lymphoid
×
30 days
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled